Search by Drug Name or NDC

    NDC 00228-2856-09 Pregabalin 25 mg/1 Details

    Pregabalin 25 mg/1

    Pregabalin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is PREGABALIN.

    Product Information

    NDC 00228-2856
    Product ID 0228-2856_5e9e2d86-0a5f-48cd-9f99-99ddb040c7fd
    Associated GPIs 72600057000110
    GCN Sequence Number 057799
    GCN Sequence Number Description pregabalin CAPSULE 25 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 23039
    HICL Sequence Number 026470
    HICL Sequence Number Description PREGABALIN
    Brand/Generic Generic
    Proprietary Name Pregabalin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Pregabalin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name PREGABALIN
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class n/a
    DEA Schedule CV
    Marketing Category ANDA
    Application Number ANDA091025
    Listing Certified Through n/a

    Package

    NDC 00228-2856-09 (00228285609)

    NDC Package Code 0228-2856-09
    Billing NDC 00228285609
    Package 90 CAPSULE in 1 BOTTLE (0228-2856-09)
    Marketing Start Date 2020-09-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.06565
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description PREGABALIN 25 MG CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis